Teva Sues To Invalidate Nexium Patents
"AstraZeneca is confident in the strength of its patent protection regarding Nexium and will vigorously protect its intellectual property," said Astrazeneca representative Blair Hains on Wednesday.
In November 2005, AstraZeneca sued Teva and other generics makers, including Ranbaxy Pharmaceuticals Inc. and Ivax Corp., for allegedly planning to infringe several patents related to Nexium.
Teva's new lawsuit seeks...
To view the full article, register now.